IDEAYA Biosciences Inc

IDYAStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$36.61

Today

-3.8%

YTD

+6.1%

About

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company revered for its efforts in oncology drug discovery. Operating globally, the company focuses on developing precision medicine targeting cancer vulnerabilities. IDEAYA Biosciences, Inc. operates primarily in the healthcare sector, where it is committed to creating targeted therapeutics using molecular diagnostics. Its portfolio of pipeline programs includes darovasertib (IDE196), a clinical-stage PKC inhibitor for genetically defined cancers. Find IDYA price updates and further information on eToro.

Price chart

Closing price history for IDYA (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-19.59

P/S (TTM)14.97

P/B (TTM)3.06

Market cap$3.67B

Cap tierMid-cap

Industry avg P/E-7.28

Profitability

Gross margin98.08%

EBIT margin-92.66%

Net margin-1269.64%

ROE-16.22%

ROA-14.89%

Earnings & Revenue

Revenue (TTM)$234.13M

Revenue growth (1Y)+3244.7%

EPS (TTM)-$1.94

Free cash flow$-113.87M

Total debt$29.31M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.19

Employees145

Next earnings9 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.